{"id":3996,"date":"2020-08-26T09:17:53","date_gmt":"2020-08-26T09:17:53","guid":{"rendered":"https:\/\/clinlabint.3wstaging.nl\/immuno-turbidimetric-fecal-calprotectin-assay\/"},"modified":"2021-01-08T11:27:16","modified_gmt":"2021-01-08T11:27:16","slug":"immuno-turbidimetric-fecal-calprotectin-assay","status":"publish","type":"post","link":"https:\/\/clinlabint.com\/immuno-turbidimetric-fecal-calprotectin-assay\/","title":{"rendered":"Immuno-turbidimetric fecal Calprotectin Assay"},"content":{"rendered":"

Fecal calprotectin (fCAL) is the most important marker for in vitro diagnostic detection of gut inflammation. Immunological quantitation is well established and is used in the diagnostic work-up of inflammatory bowel diseases (IBD) and in the lifelong monitoring of these chronic conditions.
fCAL testing today requires a raised level of lab resources including stool sample handling, extraction and the use of traditional immunological testing methods, i.e. ELISA.
The B\u00dcHLMANN fCAL turbo assay is a big step towards full automation. It reduces the time to result to 10 minutes and the total hands-on time significantly. It offers the possibility of random access on your existing clinical chemistry platform. Validated applications are available for many analysers.
The combination with the proprietary extraction device CALEX Cap for pre-analytical sample preparation simplifies and accelerates stool diagnostics significantly. The B\u00dcHLMANN fCAL turbo utilizes the well-established standardization of the B\u00dcHLMANN fCAL ELISA to provide reliability, comparability and continuity of measurements.<\/p>\n


\nSupplier:<\/strong> B\u00dcHLMANN Laboratories AG
\nWebsite:<\/strong> <\/a><\/p>\n

Mail the supplier<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Fecal calprotectin (fCAL) is the most important marker for in vitro diagnostic detection of gut inflammation. Immunological quantitation is well established and is used in the diagnostic work-up of inflammatory bowel diseases (IBD) and in the lifelong monitoring of these chronic conditions.fCAL testing today requires a raised level of lab resources including stool sample handling, […]<\/p>\n","protected":false},"author":2,"featured_media":10156,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[39],"tags":[],"_links":{"self":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/3996"}],"collection":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/comments?post=3996"}],"version-history":[{"count":0,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/3996\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/media\/10156"}],"wp:attachment":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/media?parent=3996"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/categories?post=3996"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/tags?post=3996"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}